The place of combined mucoactive drugs in the treatment of acute respiratory infections in children
The problem of respiratory diseases and their therapy options still retains much of its urgency. Respiratory diseases in children are still super common. According to the data on infectious morbidity among children in the Russian Federation for the period 2018–2020, current trends have not changed,...
Main Author: | L. S. Starostina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2022-01-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6615 |
Similar Items
-
Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis
by: Andrey A. Zaitsev, et al.
Published: (2023-04-01) -
Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections
by: Helmut H. Albrecht, et al.
Published: (2017-12-01) -
A pilot study of safety of sulfamethoxazole, trimethoprim and guaifenesin in pediatric and adult patients with acute bronchitis
by: Mayer Falcon, et al.
Published: (2019-03-01) -
Mucoactive therapy for impaired respiratory function in children with acute bronchitis
by: L. S. Ovcharenko, et al.
Published: (2020-12-01) -
Is protracted bacterial bronchitis a new nosological group or an old problem of differential diagnosis of chronic cough in children?
by: S. I. Ilchenko, et al.
Published: (2019-07-01)